Reference
[Please submit your publication]
|
Karling T, Weavers H.<br> Immune cells adapt to confined environments in vivo to optimise nuclear plasticity for migration.<br> EMBO Rep (2025) 26(5) 1238-1268
[
PubMed ID = 39915297
]
[
RRC reference
]
Kosakamoto H, Fujisawa Y, Obata F, Miura M.<br> High expression of A-type lamin in the leading front is required for Drosophila thorax closure.<br> Biochem Biophys Res Commun (2018) 499(2) 209-214
[
PubMed ID = 29559239
]
[
RRC reference
]
Uchino R, Nonaka YK, Horigome T, Sugiyama S, Furukawa K.<br> Loss of Drosophila A-type lamin C initially causes tendon abnormality including disintegration of cytoskeleton and nuclear lamina in muscular defects.<br> Dev Biol (2013) 373(1) 216-27
[
PubMed ID = 22982669
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 100 |
482 |
0 |
2 |
5 |
NM_079018.2 |
CG10119-RA (LamC), mRNA |
| 0.41 |
2 |
16 |
20 |
29 |
NM_057268.3 |
CG6944-RA (Lam), mRNA |
| 0.41 |
2 |
3 |
5 |
2 |
NM_170095.1 |
CG31141-RA (CG31141), mRNA |
| 0.2 |
1 |
3 |
2 |
6 |
NM_080334.2 |
CG7038-RA (mRpL30), mRNA |
| 0 |
0 |
4 |
2 |
13 |
NM_001043297.1 |
CG3339-RB, transcript variant B (CG3339), mRNA |
| 0 |
0 |
4 |
2 |
11 |
NM_143300.1 |
CG3339-RA, transcript variant A (CG3339), mRNA |
| 0 |
0 |
4 |
2 |
7 |
NM_167364.1 |
CG15747-RA (CG15747), mRNA |
| 0 |
0 |
3 |
5 |
5 |
NM_078544.2 |
CG1689-RA (lz), mRNA |
| 0 |
0 |
3 |
4 |
5 |
NM_079593.3 |
CG17228-RC, transcript variant C (pros), mRNA |
| 0 |
0 |
3 |
4 |
5 |
NM_176459.1 |
CG17228-RD, transcript variant D (pros), mRNA |
| 0 |
0 |
3 |
4 |
5 |
NM_169386.1 |
CG17228-RA, transcript variant A (pros), mRNA |
| 0 |
0 |
3 |
4 |
5 |
NM_079059.2 |
CG5519-RA (Gbp), mRNA |
| 0 |
0 |
3 |
4 |
3 |
NM_134486.1 |
CG14221-RA (CG14221), mRNA |
| 0 |
0 |
3 |
2 |
4 |
NM_079148.2 |
CG6883-RA, transcript variant A (trh), mRNA |
| 0 |
0 |
3 |
2 |
4 |
NM_001043110.1 |
CG6883-RB, transcript variant B (trh), mRNA |
| 0 |
0 |
3 |
2 |
3 |
NM_168712.2 |
CG6652-RB, transcript variant B (CG6652), mRNA |
| 0 |
0 |
3 |
2 |
3 |
NM_140689.3 |
CG6652-RA, transcript variant A (CG6652), mRNA |
| 0 |
0 |
3 |
2 |
2 |
NM_164497.1 |
CG2903-RA, transcript variant A (Hrs), mRNA |
| 0 |
0 |
3 |
2 |
2 |
NM_164496.1 |
CG2903-RC, transcript variant C (Hrs), mRNA |
| 0 |
0 |
3 |
2 |
2 |
NM_080360.3 |
CG2903-RB, transcript variant B (Hrs), mRNA |
| 0 |
0 |
2 |
10 |
7 |
NM_001038881.1 |
CG3257-RB, transcript variant B (CG3257), mRNA |
| 0 |
0 |
2 |
10 |
7 |
NM_138043.3 |
CG3257-RA, transcript variant A (CG3257), mRNA |
| 0 |
0 |
2 |
9 |
2 |
NM_137107.1 |
CG13942-RA (CG13942), mRNA |
| 0 |
0 |
2 |
5 |
10 |
NM_139422.2 |
CG1017-RA (CG1017), mRNA |
| 0 |
0 |
2 |
5 |
8 |
NM_132380.1 |
CG15311-RA (CG15311), mRNA |
| 0 |
0 |
2 |
4 |
10 |
NM_165220.1 |
CG6605-RA (BicD), mRNA |
| 0 |
0 |
2 |
4 |
5 |
NM_139839.3 |
CG32381-RA (unc-13-4A), mRNA |
| 0 |
0 |
2 |
4 |
2 |
NM_165918.1 |
CG30055-RA (CG30055), mRNA |
| 0 |
0 |
2 |
2 |
10 |
NM_169685.1 |
CG8884-RC, transcript variant C (Sap47), mRNA |
| 0 |
0 |
2 |
2 |
10 |
NM_169689.1 |
CG8884-RG, transcript variant G (Sap47), mRNA |
|